WARNING: This product is for research use only, not for human or veterinary use.
MedKoo CAT#: 522527
CAS#: 892549-43-8
Description: MF-63 is a novel and selective mPGES-1 inhibitor. MF63 potently inhibited the human mPGES-1 enzyme (IC(50) = 1.3 nM), with a high degree (>1000-fold) of selectivity over other prostanoid synthases. In rodent species, MF63 strongly inhibited guinea pig mPGES-1 (IC(50) = 0.9 nM) but not the mouse or rat enzyme. MF63 did not cause NSAID-like gastrointestinal toxic effects, such as mucosal erosions or leakage in the KI mice or nonhuman primates, although it markedly inhibited PGE(2) synthesis in the KI mouse stomach.
MedKoo Cat#: 522527
Name: MF-63
CAS#: 892549-43-8
Chemical Formula: C23H11ClN4
Exact Mass: 378.0672
Molecular Weight: 378.82
Elemental Analysis: C, 72.92; H, 2.93; Cl, 9.36; N, 14.79
MF-63, purity > 98%, is in stock. Current shipping out time is about 2 weeks after order is received. CoA, QC data and MSDS documents are available in one week after order is received.
Synonym: MF-63; MF63; MF 63
IUPAC/Chemical Name: 2-(6-chloro-1H-phenanthro[9,10-d]imidazol-2-yl)-isophthalonitrile
InChi Key: BVFLHOOKHPFDCT-UHFFFAOYSA-N
InChi Code: InChI=1S/C23H11ClN4/c24-15-8-9-18-19(10-15)16-6-1-2-7-17(16)21-22(18)28-23(27-21)20-13(11-25)4-3-5-14(20)12-26/h1-10H,(H,27,28)
SMILES Code: N#CC1=CC=CC(C#N)=C1C2=NC3=C4C=CC(Cl)=CC4=C5C=CC=CC5=C3N2
The following data is based on the product molecular weight 378.82 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
1: Xu D, Rowland SE, Clark P, Giroux A, Côté B, Guiral S, Salem M, Ducharme Y,
Friesen RW, Méthot N, Mancini J, Audoly L, Riendeau D. MF63
[2-(6-chloro-1H-phenanthro[9,10-d]imidazol-2-yl)-isophthalonitrile], a selective
microsomal prostaglandin E synthase-1 inhibitor, relieves pyresis and pain in
preclinical models of inflammation. J Pharmacol Exp Ther. 2008 Sep;326(3):754-63.
doi: 10.1124/jpet.108.138776. Epub 2008 Jun 4. PubMed PMID: 18524979.
Microsomal prostaglandin E synthase-1 (mPGES-1) is a terminal prostaglandin E(2) (PGE(2)) synthase in the cyclooxygenase pathway. Inhibitors of mPGES-1 may block PGE(2) production and relieve inflammatory symptoms.
